Skip to main content

Table 2 Acute and long-term results

From: Benefits of whole-body vibration to people with COPD: a community-based efficacy trial

WBV

PWBV

 

Baseline

Week 3

Week 6

Week 9

Week 11

Week 14

Borg CR-10 VAS

1(1)

2(2)

2(1)

1(1)

1(1)

2(1)

2(1)

2(2)

2(1)

2(1)

2(1)

2(1)

HR (beats min-1)

82(10)

92(10)*

86(11)

94(12)*

83(11)

95(9)*

81(13)

88(13)

83(10)

88(13)

83(11)

90(8)

SpO2 (%)

97(2)

96(2)

96(2)

96(2)

95(2)

96(1)

95(2)

96(2)

96(2)

96(1)

94(2)

95(2)

TUG (sec)

11.3 (1.9)

 

10.7(1.7)*

 

9.8(1.9)*

 

10.8(2.2)

 

10.7(3.9)

 

10.6(1.7)

 

5-chair (sec)

18.5(3.4)

 

16.4(2.7)*

 

15.1(2.4)*

 

16.1(2.4)

 

16.3(3.5)

 

16.3(2.8)

 

SL (m)

1.14(0.16)

 

1.19(0.17)+

 

1.27(0.11)+

 

1.22(0.11)

 

1.20(0.13)

 

1.22(0.30)

 

ST (sec)

1.11(0.13)

 

1.09(0.12)+

 

1.10(0.06)+

 

1.03(0.10)

 

1.02(0.09)

 

1.02(0.11)

 

SVel (m.sec-1)

1.04(0.15)

 

1.10(0.15)+

 

1.16(0.11)+

 

1.19(0.15)

 

1.18(0.16)

 

1.20(0.16)

 
  1. Results are mean (SD). Pre: pre bout. During: during the bout. HR: heart rate. SpO2: oxygen saturation. TUG: timed-up-and-go test. %-chair: 5-chair stands test. SL: stride length. ST: stride time. SVel: stride velocity. *p ≤ 0.05. + p ≤ 0.02.
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us